+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cervical Cancer Diagnostic Testing - Global Market Trajectory & Analytics

  • ID: 5027990
  • Report
  • July 2020
  • Region: Global
  • 181 pages
  • Global Industry Analysts, Inc
1 of 2
Global Cervical Cancer Diagnostic Testing Market to Reach $8.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Cervical Cancer Diagnostic Testing estimated at US$5.9 Billion in the year 2020, is projected to reach a revised size of US$8.2 Billion by 2027, growing at aCAGR of 4.9% over the period 2020-2027. Pap Smear Test, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$5.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the HPV Testing segment is readjusted to a revised 6.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 7.4% CAGR

The Cervical Cancer Diagnostic Testing market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.We bring years of research experience to this 9th edition of our report. The 181-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Abbott Laboratories
  • Arbor Vita Corporation
  • AutoGenomics, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • BioVantra, LLC
  • Cancer Genetics, Inc.
  • Cepheid, Inc.
  • Cytoimmun Diagnostics GmbH
  • Daan Gene Co., Ltd.
  • DiaCarta, Inc.
  • F. Hoffmann-La Roche AG
  • Fujirebio, Inc.
  • Genera Biosystems Ltd.
  • Greiner Bio-One International GmbH
  • Guided Therapeutics, Inc.
  • GynaeHealth
  • Hologic, Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Institute
  • OralDNA Labs
  • PreTect AS
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.
  • Roche Molecular Diagnostics
  • Rovers Medical Devices
  • Seegene, Inc.
  • Solopap Australia
  • TrovaGene, Inc.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 2

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Cervical Cancer Diagnostic Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Cervical Cancer Diagnostic Testing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Cervical Cancer Diagnostic Testing Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Cervical Cancer Diagnostic Testing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Pap Smear Test (Test Type) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Pap Smear Test (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Pap Smear Test (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: HPV Testing (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: HPV Testing (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: HPV Testing (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Cervical Cancer Diagnostic Testing Market Share (in %) by Company: 2019 & 2025

Market Analytics
TABLE 10: United States Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 11: Cervical Cancer Diagnostic Testing Market in the United States by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 12: United States Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

CANADA

TABLE 13: Canadian Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 14: Canadian Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
TABLE 15: Cervical Cancer Diagnostic Testing Market in Canada: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027

JAPAN

TABLE 16: Japanese Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 17: Cervical Cancer Diagnostic Testing Market in Japan: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 18: Japanese Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

CHINA

TABLE 19: Chinese Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 20: Cervical Cancer Diagnostic Testing Historic Market Analysis in China in US$ Million by Test Type: 2012-2019
TABLE 21: Chinese Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

EUROPE

Market Facts & Figures

European Cervical Cancer Diagnostic Testing Market: Competitor Market Share Scenario (in %) for 2019 & 2025

Market Analytics
TABLE 22: European Cervical Cancer Diagnostic Testing Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 23: Cervical Cancer Diagnostic Testing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 24: European Cervical Cancer Diagnostic Testing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: European Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 26: Cervical Cancer Diagnostic Testing Market in Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 27: European Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

FRANCE

TABLE 28: Cervical Cancer Diagnostic Testing Market in France by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 29: French Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
TABLE 30: French Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

GERMANY

TABLE 31: Cervical Cancer Diagnostic Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 32: German Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 33: German Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

ITALY

TABLE 34: Italian Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 35: Cervical Cancer Diagnostic Testing Historic Market Analysis in Italy in US$ Million by Test Type: 2012-2019
TABLE 36: Italian Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

UNITED KINGDOM

TABLE 37: United Kingdom Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 38: Cervical Cancer Diagnostic Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 39: United Kingdom Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

SPAIN

TABLE 40: Spanish Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 41: Spanish Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
TABLE 42: Cervical Cancer Diagnostic Testing Market in Spain: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027

RUSSIA

TABLE 43: Russian Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 44: Cervical Cancer Diagnostic Testing Market in Russia by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 45: Russian Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

REST OF EUROPE

TABLE 46: Rest of Europe Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 47: Cervical Cancer Diagnostic Testing Market in Rest of Europe in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 48: Rest of Europe Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

ASIA-PACIFIC

TABLE 49: Asia-Pacific Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 50: Cervical Cancer Diagnostic Testing Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
TABLE 51: Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
TABLE 52: Cervical Cancer Diagnostic Testing Market in Asia-Pacific by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 53: Asia-Pacific Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
TABLE 54: Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

AUSTRALIA

TABLE 55: Cervical Cancer Diagnostic Testing Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 56: Australian Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 57: Australian Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

INDIA

TABLE 58: Indian Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 59: Indian Cervical Cancer Diagnostic Testing Historic Market Review by Test Type in US$ Million: 2012-2019
TABLE 60: Cervical Cancer Diagnostic Testing Market in India: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and 2027

SOUTH KOREA

TABLE 61: Cervical Cancer Diagnostic Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 62: South Korean Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 63: Cervical Cancer Diagnostic Testing Market Share Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC

TABLE 64: Rest of Asia-Pacific Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 65: Cervical Cancer Diagnostic Testing Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 66: Rest of Asia-Pacific Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

LATIN AMERICA

TABLE 67: Latin American Cervical Cancer Diagnostic Testing Market Trends by Region/Country in US$ Million: 2020-2027
TABLE 68: Cervical Cancer Diagnostic Testing Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 69: Latin American Cervical Cancer Diagnostic Testing Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
TABLE 70: Latin American Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 71: Cervical Cancer Diagnostic Testing Historic Market Analysis in Latin America in US$ Million by Test Type: 2012-2019
TABLE 72: Latin American Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

ARGENTINA

TABLE 73: Argentinean Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 74: Cervical Cancer Diagnostic Testing Market in Argentina in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 75: Argentinean Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

BRAZIL

TABLE 76: Cervical Cancer Diagnostic Testing Market in Brazil by Test Type: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 77: Brazilian Cervical Cancer Diagnostic Testing Historic Market Scenario in US$ Million by Test Type: 2012-2019
TABLE 78: Brazilian Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

MEXICO

TABLE 79: Cervical Cancer Diagnostic Testing Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 80: Mexican Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 81: Mexican Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA

TABLE 82: Rest of Latin America Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 83: Cervical Cancer Diagnostic Testing Market in Rest of Latin America by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 84: Rest of Latin America Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

MIDDLE EAST

TABLE 85: The Middle East Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 86: Cervical Cancer Diagnostic Testing Market in the Middle East by Region/Country in US$ Million: 2012-2019
TABLE 87: The Middle East Cervical Cancer Diagnostic Testing Market Share Breakdown by Region/Country: 2012, 2020, and 2027
TABLE 88: The Middle East Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to 2027
TABLE 89: The Middle East Cervical Cancer Diagnostic Testing Historic Market by Test Type in US$ Million: 2012-2019
TABLE 90: Cervical Cancer Diagnostic Testing Market in the Middle East: Percentage Share Breakdown of Sales by Test Type for 2012,2020, and 2027

IRAN

TABLE 91: Iranian Market for Cervical Cancer Diagnostic Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020-2027
TABLE 92: Cervical Cancer Diagnostic Testing Market in Iran: Historic Sales Analysis in US$ Million by Test Type for the Period 2012-2019
TABLE 93: Iranian Cervical Cancer Diagnostic Testing Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

ISRAEL

TABLE 94: Israeli Cervical Cancer Diagnostic Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020-2027
TABLE 95: Cervical Cancer Diagnostic Testing Market in Israel in US$ Million by Test Type: A Historic Review for the Period 2012-2019
TABLE 96: Israeli Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

SAUDI ARABIA

TABLE 97: Saudi Arabian Cervical Cancer Diagnostic Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020-2027
TABLE 98: Cervical Cancer Diagnostic Testing Historic Market Analysis in Saudi Arabia in US$ Million by Test Type: 2012-2019
TABLE 99: Saudi Arabian Cervical Cancer Diagnostic Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

UNITED ARAB EMIRATES

TABLE 100: Cervical Cancer Diagnostic Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 101: United Arab Emirates Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 102: Cervical Cancer Diagnostic Testing Market Share Distribution in United Arab Emirates by Test Type: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST

TABLE 103: Cervical Cancer Diagnostic Testing Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020-2027
TABLE 104: Rest of Middle East Cervical Cancer Diagnostic Testing Historic Market Analysis in US$ Million by Test Type: 2012-2019
TABLE 105: Rest of Middle East Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

AFRICA

TABLE 106: African Cervical Cancer Diagnostic Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to 2027
TABLE 107: Cervical Cancer Diagnostic Testing Market in Africa by Test Type: A Historic Review in US$ Million for 2012-2019
TABLE 108: African Cervical Cancer Diagnostic Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

IV. COMPETITION

Total Companies Profiled: 43

Note: Product cover images may vary from those shown
Adroll
adroll